| Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ... New England Journal of Medicine 370 (22), 2071-2082, 2014 | 4433 | 2014 |
| An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias WD Travis, U Costabel, DM Hansell, TE King Jr, DA Lynch, AG Nicholson, ... American journal of respiratory and critical care medicine 188 (6), 733-748, 2013 | 3844 | 2013 |
| EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis M Yates, RA Watts, IM Bajema, MC Cid, B Crestani, T Hauser, B Hellmich, ... Annals of the rheumatic diseases 75 (9), 1583-1594, 2016 | 1368 | 2016 |
| Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, L Richeldi, CC Thomson, Y Inoue, T Johkoh, ... American Journal of Respiratory and Critical Care Medicine 205 (9), e18-e47, 2022 | 1165 | 2022 |
| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 900 | 2021 |
| ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international … WD Travis, U Costabel, DM Hansell, TE King Jr, DA Lynch, AG Nicholson, ... Am J Respir Crit Care Med 188 (6), 733-48, 2013 | 616 | 2013 |
| Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis N Riteau, P Gasse, L Fauconnier, A Gombault, M Couegnat, L Fick, ... American journal of respiratory and critical care medicine 182 (6), 774-783, 2010 | 475 | 2010 |
| Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ... The lancet Respiratory medicine 8 (5), 453-460, 2020 | 447 | 2020 |
| MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease PA Juge, JS Lee, E Ebstein, H Furukawa, E Dobrinskikh, S Gazal, ... New England Journal of Medicine 379 (23), 2209-2219, 2018 | 398 | 2018 |
| NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into … N Amara, D Goven, F Prost, R Muloway, B Crestani, J Boczkowski Thorax 65 (8), 733-738, 2010 | 362 | 2010 |
| Pulmonary alveolar proteinosis R Borie, C Danel, MP Debray, C Taille, MC Dombret, M Aubier, R Epaud, ... European Respiratory Review 20 (120), 98-107, 2011 | 332 | 2011 |
| Compartmentalized cytokine production within the human lung in unilateral pneumonia. MS Dehoux, A Boutten, J Ostinelli, N Seta, MC Dombret, B Crestani, ... American journal of respiratory and critical care medicine 150 (3), 710-716, 1994 | 309 | 1994 |
| Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death M Wislez, N Rabbe, J Marchal, B Milleron, B Crestani, C Mayaud, ... Cancer research 63 (6), 1405-1412, 2003 | 297 | 2003 |
| Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. A Bellocq, M Antoine, A Flahault, C Philippe, B Crestani, JF Bernaudin, ... The American journal of pathology 152 (1), 83, 1998 | 297 | 1998 |
| The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis A Guenther, E Krauss, S Tello, J Wagner, B Paul, S Kuhn, O Maurer, ... Respiratory research 19, 1-10, 2018 | 283 | 2018 |
| Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris B Duchemann, I Annesi-Maesano, CJ de Naurois, S Sanyal, PY Brillet, ... European Respiratory Journal 50 (2), 2017 | 283 | 2017 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 282 | 2021 |
| Rodletless mutants of Aspergillus fumigatus N Thau, M Monod, B Crestani, C Rolland, G Tronchin, JP Latge, S Paris Infection and immunity 62 (10), 4380-4388, 1994 | 275 | 1994 |
| Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection J Frija-Masson, MP Debray, M Gilbert, FX Lescure, F Travert, R Borie, ... European Respiratory Journal 56 (2), 2020 | 248 | 2020 |
| Clinical characteristics and prognostic factors of pulmonary MALT lymphoma R Borie, M Wislez, G Thabut, M Antoine, A Rabbat, LJ Couderc, I Monnet, ... European Respiratory Journal 34 (6), 1408-1416, 2009 | 247 | 2009 |
